Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer

Free Subscription Articles published in Int J Gynaecol Obstet Retrieve available abstracts of 105 articles: HTML format

Single Articles

June 2026
1. WATCHARASIN P, Sirimusika N, Atjimakul T, Rattanaburi A, et al
   Diagnostic performance of human papillomavirus DNA cycle threshold values in the detection of high-grade cervical intraepithelial neoplasia.
   Int J Gynaecol Obstet. 2026;173:1617-1627.
   PubMed     Abstract available
   
   
   May 2026
2. RUSSELL JC, Amin S, Kohler RE, Kelly H, et al
   Understanding barriers to cervical cancer screening in Botswana: Insights from a cross-sectional study.
   Int J Gynaecol Obstet. 2026 May 26. doi: 10.1002/ijgo.71089.
   PubMed     Abstract available
   
   
   
3. YANG Y, Yu M, Zeng M
   Distant metastasis in patients with cervical cancer: A systematic review and meta-analysis of incidence rates and common sites.
   Int J Gynaecol Obstet. 2026 May 22. doi: 10.1002/ijgo.71092.
   PubMed     Abstract available
   
   
   April 2026
4. JIAMSET I, Nanthamongkolkul K, Kongkamsuan W, Saeaib N, et al
   Neutrophil-to-lymphocyte ratio as a prognostic marker for survival outcomes in women with cervical cancer and HIV infection.
   Int J Gynaecol Obstet. 2026 Apr 14. doi: 10.1002/ijgo.71016.
   PubMed     Abstract available
   
   
   
5. DOMINONI M, Rasore G, Pano MR, Gardella B, et al
   "Side effects" of cervical cancer screening: How diagnosis can impact on women's emotional status. A pilot survey.
   Int J Gynaecol Obstet. 2026 Apr 2. doi: 10.1002/ijgo.71005.
   PubMed    
   
   
   
6. HO QN, Quang Le T, Pham AHT, Nguyen PN, et al
   Efficacy of thermal ablation among women with cervical intraepithelial neoplasia grade 1 and high-risk human papillomavirus genotypes: The first prospective study in Vietnam.
   Int J Gynaecol Obstet. 2026;173:411-421.
   PubMed     Abstract available
   
   
   
7. LIU X, Lyu Q, Li X, He L, et al
   Interaction between the level of human papillomavirus integration and human papillomavirus type on the risk of grade 3 cervical intraepithelial neoplasia or more severe in human papillomavirus integration positive women: A cross-sectional study.
   Int J Gynaecol Obstet. 2026;173:187-195.
   PubMed     Abstract available
   
   
   
8. GULHAN I, Orun H, Yanigli G, Cagiran RN, et al
   Human papillomavirus positivity and cervical intraepithelial lesion in cervical biopsy and endocervical curettage in women younger than 30 years.
   Int J Gynaecol Obstet. 2026;173:209-215.
   PubMed     Abstract available
   
   
   
9. MOEIN S, Romo FAL, Fischel LB, Singh N, et al
   Fluorescein colposcopy-A more specific diagnostic method for detection of high-grade cervical precancer lesions than acetic acid.
   Int J Gynaecol Obstet. 2026;173:138-143.
   PubMed     Abstract available
   
   
   March 2026
10. TJALMA W
    Letter to the Editor: Sentinel node biopsy in cervical cancer during pregnancy: The need for clarification in FIGO guidance.
    Int J Gynaecol Obstet. 2026 Mar 27. doi: 10.1002/ijgo.70986.
    PubMed    
    
    
    
11. ZULFIKAROGLU E
    Cervical cancer screening strategies in women 65 years and older in the human papillomavirus era: A systematic review and meta-analysis of human papillomavirus-based testing and self-sampling approaches.
    Int J Gynaecol Obstet. 2026 Mar 12. doi: 10.1002/ijgo.70962.
    PubMed     Abstract available
    
    
    February 2026
12. DUQUE CAB, Bach RB, Fleider L, Sanchez-Diaz E, et al
    Colposcopists' practice patterns in Latin America: An international cross-sectional survey.
    Int J Gynaecol Obstet. 2026;172:808-814.
    PubMed     Abstract available
    
    
    
13. ZHANG H, Dai Y, Zhou H, Yang Y, et al
    Application of P16/Ki-67 dual-staining for the detection of high-grade cervical lesions in the triage of patients with minor abnormal cytology: A meta-analysis.
    Int J Gynaecol Obstet. 2026;172:815-827.
    PubMed     Abstract available
    
    
    January 2026
14. HOFFMANN S, Trif L, Kramer B, Neis F, et al
    PelviSound L-Real-time intraoperative sonographic assessment of pelvic sentinel lymph nodes using a drop-in probe in endometrial and cervical cancer during minimally invasive surgery: A single-center pilot feasibility study in 20 patients.
    Int J Gynaecol Obstet. 2026 Jan 29. doi: 10.1002/ijgo.70838.
    PubMed     Abstract available
    
    
    
15. MUSA MS, Swai P, Oneko O, Mmbaga B, et al
    Three-year survival rate and associated factors among women with invasive cervical cancer attended at ocean road cancer institute, Tanzania.
    Int J Gynaecol Obstet. 2026 Jan 22. doi: 10.1002/ijgo.70831.
    PubMed     Abstract available
    
    
    
16. IMARENGIAYE EO, Iweka RO, Anya CJ, Nwaogwugwu JC, et al
    Knowledge, acceptance, uptake barriers and missed opportunities of human papillomavirus vaccine among female adolescents in Benin City, Nigeria: A mixed method study.
    Int J Gynaecol Obstet. 2026;172:373-382.
    PubMed     Abstract available
    
    
    December 2025
17. MANISHA M, Singh P, Yadav G, Gothwal M, et al
    Genotype-specific Human Papillomavirus patterns and their implications across the cervical cancer spectrum: A cross-sectional study from Western India.
    Int J Gynaecol Obstet. 2025 Dec 12. doi: 10.1002/ijgo.70730.
    PubMed     Abstract available
    
    
    November 2025
18. ZHU A, Ma Y, Chen F, Zhou L, et al
    Clinicopathologic characteristics and prognostic outcomes of surgically treated neuroendocrine cervical carcinoma: A single institution retrospective analysis.
    Int J Gynaecol Obstet. 2025 Nov 27. doi: 10.1002/ijgo.70697.
    PubMed     Abstract available
    
    
    
19. HINOJOSA-GONZALEZ DE, Escarcega-Bordagaray JA, Murillo-Torres RM, Torres-Martinez M, et al
    Immune checkpoint therapy in locally advanced, persistent, recurrent, and metastatic cervical cancer: A systematic review and Bayesian network meta-analysis.
    Int J Gynaecol Obstet. 2025 Nov 15. doi: 10.1002/ijgo.70648.
    PubMed     Abstract available
    
    
    
20. FUJITA H, Okamoto K, Kato H, Watari H, et al
    Combination of transvaginal ultrasound with cervical cancer screening contributes to early detection of ovarian cancer: Clinical trial.
    Int J Gynaecol Obstet. 2025 Nov 3. doi: 10.1002/ijgo.70599.
    PubMed     Abstract available
    
    
    October 2025
21. URBANO FP, Cury GR, Dos Santos CR, da Silva DJC, et al
    Introduction of DNA-HPV test in the Brazilian cervical cancer screening program: When the idea is good but does not fit the budget.
    Int J Gynaecol Obstet. 2025 Oct 14. doi: 10.1002/ijgo.70594.
    PubMed     Abstract available
    
    
    
22. YANG XL, Zeng Z, Yan JF, Zhang FQ, et al
    Does the addition of radiation to adjuvant chemotherapy improve the survival for early-stage (tumor size
    Int J Gynaecol Obstet. 2025;171:362-370.
    PubMed     Abstract available
    
    
    September 2025
23. SINGLA A, Mehta S, Grover A, Mishra AK, et al
    Cervical cancer screening: Is self-sampling the answer?
    Int J Gynaecol Obstet. 2025 Sep 30. doi: 10.1002/ijgo.70562.
    PubMed     Abstract available
    
    
    
24. MARSHALL A, Pareja R, Ruzindana K, Bhatla N, et al
    FIGO position statement on the effectiveness and safety of the HPV vaccine.
    Int J Gynaecol Obstet. 2025 Sep 3. doi: 10.1002/ijgo.70506.
    PubMed     Abstract available
    
    
    
25. SANTIAGO SANABRIA L, Laverde Cardona VA, Perez D YR, Abreu F, et al
    Barriers in the prevention and early detection of human papillomavirus in Latin America.
    Int J Gynaecol Obstet. 2025;170:1144-1152.
    PubMed     Abstract available
    
    
    
26. YANAIHARA N, Tse KY, Lee SJ, Yoo JG, et al
    Immune checkpoint inhibitors in gynecologic oncology: Current status and perspectives.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:166-188.
    PubMed     Abstract available
    
    
    
27. WILAILAK S, Kengsakul M, Kehoe S
    Strategic approaches for global cervical cancer elimination: An update review and call for national action.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:120-128.
    PubMed     Abstract available
    
    
    
28. BHATLA N, Aoki D, Sharma DN, Sankaranarayanan R, et al
    Cancer of the cervix uteri: 2025 update.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:87-108.
    PubMed     Abstract available
    
    
    
29. RUZINDANA K, Anorlu RI
    Global disparities in gynecologic cancer outcomes: A call for action.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:210-220.
    PubMed     Abstract available
    
    
    August 2025
30. ZHANG C, Zhou H, Liu Y, Dai Y, et al
    Association of HPV16/18 genotype infection with the Silva pattern classification system in human papilloma virus-associated endocervical adenocarcinomas.
    Int J Gynaecol Obstet. 2025;170:893-900.
    PubMed     Abstract available
    
    
    July 2025
31. MORA-SOTO N, Morante-Caicedo C, Caicedo-Martinez M, Viveros-Carreno D, et al
    Morbidity of radical surgery and postoperative radiotherapy in cervical cancer.
    Int J Gynaecol Obstet. 2025 Jul 30. doi: 10.1002/ijgo.70281.
    PubMed     Abstract available
    
    
    
32. LI Z, Wang P, Lu D, Ding Z, et al
    Development and validation of a risk prediction model for lower limb lymphedema in postoperative cervical cancer patients.
    Int J Gynaecol Obstet. 2025 Jul 30. doi: 10.1002/ijgo.70423.
    PubMed     Abstract available
    
    
    
33. MCCLUGGAGE WG
    New histopathological and molecular findings in gynecological cancers.
    Int J Gynaecol Obstet. 2025 Jul 30. doi: 10.1002/ijgo.70283.
    PubMed     Abstract available
    
    
    
34. AKINYEMI O, Ogunyankin F, Fasokun M, Abodunrin F, et al
    Medicaid expansion and overall mortality among women with cervical cancer.
    Int J Gynaecol Obstet. 2025 Jul 19. doi: 10.1002/ijgo.70354.
    PubMed     Abstract available
    
    
    
35. PERALTA J, Rodriguez J, Acosta JA, Nunez M, et al
    Management of invasive cervical carcinoma in three oncology centers in Latin America: A historical cohort study.
    Int J Gynaecol Obstet. 2025 Jul 17. doi: 10.1002/ijgo.70371.
    PubMed     Abstract available
    
    
    
36. KARATAS E, Salman MC, Basaran D, Akgor U, et al
    Predictors of lymphocyst development following lymphadenectomy in patients with gynecologic cancer.
    Int J Gynaecol Obstet. 2025 Jul 17. doi: 10.1002/ijgo.70377.
    PubMed     Abstract available
    
    
    
37. ASICIOGLU O, Ates S, Varol F, Yalta TD, et al
    Oncologic outcome and recurrence patterns of clinical stage IB and IIA cervical cancer: A large retrospective analysis of a tertiary reference center.
    Int J Gynaecol Obstet. 2025 Jul 15. doi: 10.1002/ijgo.70366.
    PubMed     Abstract available
    
    
    
38. ZHANG J, Wang Y, Li H
    Research progress of adoptive tumor infiltrating lymphocyte therapy for cervical cancer.
    Int J Gynaecol Obstet. 2025 Jul 10. doi: 10.1002/ijgo.70360.
    PubMed     Abstract available
    
    
    
39. LI M, Xu S, Yang Q, Zheng Z, et al
    Epidemiological trends of gynecologic cancer burden in east Asian countries from 1990 to 2021 and projections to 2031.
    Int J Gynaecol Obstet. 2025 Jul 4. doi: 10.1002/ijgo.70351.
    PubMed     Abstract available
    
    
    
40. SEO JH, Yang TS, Kim HS, Cho WK, et al
    Prognostic impact of primary surgery in human papillomavirus-independent, advanced or metastatic endocervical adenocarcinoma: A bi-institutional retrospective study.
    Int J Gynaecol Obstet. 2025;170:250-258.
    PubMed     Abstract available
    
    
    
41. WU YC, Hsiao CH, Chen CH, Ko YL, et al
    Identification of vascular hotspots and analysis of micro-vessel flow velocity waveforms in high-grade squamous intraepithelial lesions of the cervix.
    Int J Gynaecol Obstet. 2025;170:200-208.
    PubMed     Abstract available
    
    
    June 2025
42. RATH S
    Rising deaths due to cervical cancer among premenopausal women in Russia: An analysis of the global burden of disease-2021.
    Int J Gynaecol Obstet. 2025 Jun 18. doi: 10.1002/ijgo.70311.
    PubMed    
    
    
    May 2025
43. DURMUS Y, Kirdag MK, Yilmaz K, Aydin E, et al
    Plexiform neurofibroma infiltrating uterine cervix and parametrium, causing hydronephrosis: A case report and review of the literature.
    Int J Gynaecol Obstet. 2025 May 16. doi: 10.1002/ijgo.70212.
    PubMed     Abstract available
    
    
    
44. LI DM, Liu QY, Xue SL, Zeng X, et al
    Accuracy analysis of cervical cancer screening using urine and vaginal self-sampling versus clinician-collected samples: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2025 May 13. doi: 10.1002/ijgo.70207.
    PubMed     Abstract available
    
    
    
45. ROMANISHIN A, Efimenko B, Katserov D, Agapov M, et al
    Comprehensive cross-sectional study of CIN prevalence, HPV genotyping, genetic alterations, and microbiota as molecular biomarkers for early cervical cancer detection: A pilot clinical study among women in Russia.
    Int J Gynaecol Obstet. 2025 May 5. doi: 10.1002/ijgo.70090.
    PubMed     Abstract available
    
    
    
46. BLADE AT, Del Mar Ramirez Mena M, de la Fuente Valero J, Sanchez RO, et al
    HPV vaccination coverage rate in women undergoing conization for cervical intraepithelial neoplasia in Spain: The COVAR study.
    Int J Gynaecol Obstet. 2025 May 2. doi: 10.1002/ijgo.70170.
    PubMed     Abstract available
    
    
    April 2025
47. PAIBOONBORIRAK C, Abu-Rustum NR, Wilailak S
    Artificial intelligence in the diagnosis and management of gynecologic cancer.
    Int J Gynaecol Obstet. 2025 Apr 25. doi: 10.1002/ijgo.70094.
    PubMed     Abstract available
    
    
    
48. SHANG X, Kong L, You Y, Wu H, et al
    Cytologic DNA methylation for managing minimally abnormal cervical cancer screening results.
    Int J Gynaecol Obstet. 2025 Apr 16. doi: 10.1002/ijgo.70167.
    PubMed     Abstract available
    
    
    
49. FUSEINI NM, El Joueidi S, Montgomery T, Lemrabott E, et al
    Cervical precancer screening and treatment in Nouakchott, Mauritania: Pilot program to inform development of Mauritania's national cervical cancer prevention program.
    Int J Gynaecol Obstet. 2025 Apr 11. doi: 10.1002/ijgo.70145.
    PubMed    
    
    
    
50. JAREEMIT N, Theerarojanapong L, Laokulrath N, Achariyapota V, et al
    Yield of endocervical curettage in detecting cervical intraepithelial neoplasia grade 2 or higher during colposcopy: A prospective, cross-sectional study.
    Int J Gynaecol Obstet. 2025;169:105-111.
    PubMed     Abstract available
    
    
    
51. GUNGORDUK K, Unver HC, Uyar BS, Ergu BN, et al
    Efficacy of chitosan powder in reducing vaginal bleeding following a loop electrosurgical excision procedure: A randomized control trial.
    Int J Gynaecol Obstet. 2025;169:240-246.
    PubMed     Abstract available
    
    
    
52. VAN DE LAAR RLO, Jordans CCE, Salmaan A, Hofhuis W, et al
    High acceptability of point-of-care HIV testing at the colposcopy outpatient clinic in hospitals in the Netherlands.
    Int J Gynaecol Obstet. 2025;169:155-162.
    PubMed     Abstract available
    
    
    March 2025
53. MIYOSHI A, Isohashi F, Fujii M, Iwamiya T, et al
    The association between additional radiotherapy after systemic chemotherapy and the prognosis of stage FIGO 2018 IVB cervical cancer.
    Int J Gynaecol Obstet. 2025 Mar 22. doi: 10.1002/ijgo.70077.
    PubMed     Abstract available
    
    
    
54. LUCKETT R, Ramogola-Masire D, Moyo S, Gompers A, et al
    Improved cervical screening using HPV type restriction and cycle threshold limit setting with the AmpFire assay: A prospective screening cohort of women with and without HIV in Botswana.
    Int J Gynaecol Obstet. 2025 Mar 19. doi: 10.1002/ijgo.70074.
    PubMed     Abstract available
    
    
    February 2025
55. CUBAKA NTAMUSHIGO J, Motshedisi Sebitloane H
    Review of triage strategies for atypical squamous cells of undetermined significance among young women.
    Int J Gynaecol Obstet. 2025;168:428-435.
    PubMed     Abstract available
    
    
    
56. YIM GW, Lee J, Yang K, Lee CH, et al
    A pilot study of upcycled smartphone-based colposcopy for visual inspection of cervix performed by community healthcare workers in rural Vietnam.
    Int J Gynaecol Obstet. 2025;168:518-524.
    PubMed     Abstract available
    
    
    December 2024
57. BIZZARRI N, Kyrgiou M, De Vincenzo R, Zapardiel I, et al
    Prophylactic HPV vaccination in HPV-related gynecologic cancers: European Society of Gynecological Oncology (ESGO) prevention committee opinion.
    Int J Gynaecol Obstet. 2024 Dec 30. doi: 10.1002/ijgo.16120.
    PubMed     Abstract available
    
    
    
58. TAKAMOTO N, Aso S, Ishida R, Konishi T, et al
    Cost-effectiveness analysis of 9-valent human papillomavirus vaccine combined with screening for cervical cancer in Japan.
    Int J Gynaecol Obstet. 2024 Dec 28. doi: 10.1002/ijgo.16125.
    PubMed     Abstract available
    
    
    
59. MUNGO C, Omoto J, Ogollah C, Owaya A, et al
    Safety and adherence to self-administered intravaginal 5-fluorouracil cream following cervical intraepithelial neoplasia (CIN) 2/3 treatment among HIV-positive women in Kenya: A phase 1 clinical trial.
    Int J Gynaecol Obstet. 2024 Dec 26. doi: 10.1002/ijgo.16093.
    PubMed     Abstract available
    
    
    
60. LYU YH, Liu HX, Han X, Yuan P, et al
    Clinicopathologic characteristics and prognostic factors of patients with surgically treated high-grade neuroendocrine carcinoma of the cervix: A multicenter retrospective study.
    Int J Gynaecol Obstet. 2024;167:1055-1065.
    PubMed     Abstract available
    
    
    November 2024
61. LIU Y, Yang S, Ma Y, Gong Y, et al
    HPV E6/E7 mRNA screening alone can be used as a screening method for cervical cancer in premenopausal women in China: A retrospective study.
    Int J Gynaecol Obstet. 2024 Nov 25. doi: 10.1002/ijgo.16043.
    PubMed     Abstract available
    
    
    
62. XU P, Mageswaran UM, Nisaa AA, Balasubramaniam SD, et al
    Roles of probiotics against HPV through the gut-vaginal axis.
    Int J Gynaecol Obstet. 2024 Nov 9. doi: 10.1002/ijgo.16005.
    PubMed     Abstract available
    
    
    
63. WU T, Sun R, Sun J, Tao X, et al
    Circulating tumor HPV DNA as a specific biomarker for cervical cancer.
    Int J Gynaecol Obstet. 2024 Nov 8. doi: 10.1002/ijgo.16011.
    PubMed     Abstract available
    
    
    October 2024
64. SADAT R, Sacinti KG, Topcu EG, Saeed S, et al
    Overcoming barriers to cervical cancer prevention in Afghanistan: The imperative for an HPV vaccination and screening program.
    Int J Gynaecol Obstet. 2024 Oct 16. doi: 10.1002/ijgo.15956.
    PubMed    
    
    
    September 2024
65. DEGENNARO V JR, Henderson RR, Petterson C, Wilson C, et al
    Working towards health: A model of cervical cancer screening and treatment for factory employees in Haiti.
    Int J Gynaecol Obstet. 2024 Sep 27. doi: 10.1002/ijgo.15940.
    PubMed     Abstract available
    
    
    
66. CAO Y, Xiao X, Liang D, Lu Y, et al
    HPV 16/18 E7 oncoprotein detection as a promising triage strategy for HPV 16/18-positive patients: A prospective multicenter study with a 2-year follow up.
    Int J Gynaecol Obstet. 2024 Sep 8. doi: 10.1002/ijgo.15897.
    PubMed     Abstract available
    
    
    August 2024
67. YURTCU E, Ozvural S, Keyif B
    Analyzing the performance of ChatGPT in answering inquiries about cervical cancer.
    Int J Gynaecol Obstet. 2024 Aug 16. doi: 10.1002/ijgo.15861.
    PubMed     Abstract available
    
    
    June 2024
68. WANG R, Ma L, Xiao Y, Jiang H, et al
    A case of postoperative non-invasive mucosal implantation of early-stage cervical adenocarcinoma to the clitoris.
    Int J Gynaecol Obstet. 2024;165:1295-1297.
    PubMed    
    
    
    
69. DESCAMPS P, Dixon S, Bosch Jose FX, Kyrgiou M, et al
    Turning the tide-Recommendations to increase cervical cancer screening among women who are underscreened.
    Int J Gynaecol Obstet. 2024;166 Suppl 1:3-21.
    PubMed    
    
    
    May 2024
70. YANG ST, Liu HH, Liu CH, Wang LW, et al
    Bevacizumab is associated with a higher gastrointestinal/genitourinary fistula or perforation risk in cervical cancer patients undergoing pelvic radiotherapy.
    Int J Gynaecol Obstet. 2024 May 15. doi: 10.1002/ijgo.15609.
    PubMed     Abstract available
    
    
    
71. ALIABADI AR, Wilailak S, McNally O, Berek JS, et al
    Contraceptive strategies for reducing the risk of reproductive cancers.
    Int J Gynaecol Obstet. 2024 May 9. doi: 10.1002/ijgo.15567.
    PubMed     Abstract available
    
    
    
72. MWANDACHA N, Dau H, AboMoslim M, Naguti P, et al
    Investigating the healthcare-seeking behaviors of mobile phone users to improve cervical cancer screening in rural Uganda.
    Int J Gynaecol Obstet. 2024 May 4. doi: 10.1002/ijgo.15577.
    PubMed     Abstract available
    
    
    April 2024
73. ALFAREH M, Obeid D, Alhoshan H, Basri R, et al
    Low uptake of Pap test as a cervical cancer screen among Saudi women: Findings from a national survey.
    Int J Gynaecol Obstet. 2024 Apr 19. doi: 10.1002/ijgo.15532.
    PubMed     Abstract available
    
    
    
74. PATEL A, Suneja A, Malik R, Gupta B, et al
    Chromocolposcopy with fluorescein sodium for detection of premalignant and malignant lesions of the cervix: A cross-sectional study.
    Int J Gynaecol Obstet. 2024;165:169-175.
    PubMed     Abstract available
    
    
    March 2024
75. HERNANDEZ JA, Rodriguez J, Rendon G, Trujillo LM, et al
    Pelvic lymph node involvement and risk of recurrence in HPV-associated endocervical adenocarcinoma stage IA2-IB1 according to Silva's system in two Colombian cancer centers.
    Int J Gynaecol Obstet. 2024 Mar 28. doi: 10.1002/ijgo.15482.
    PubMed     Abstract available
    
    
    
76. XU JY, Hu M, Wu SG, Zhou J, et al
    Local treatment strategies in Stage IVB cervical squamous cell carcinoma and adenocarcinoma.
    Int J Gynaecol Obstet. 2024;164:1053-1063.
    PubMed     Abstract available
    
    
    
77. STRATULAT V, Melamed N, Barrett J, Ladhani NNN, et al
    Cervical assessment certification and its impact on performance quality in the context of universal cervical screening.
    Int J Gynaecol Obstet. 2024;164:951-958.
    PubMed     Abstract available
    
    
    February 2024
78. MARINO-NOYA A, Magallanes-Pelaez N, Puga-Gonzalez N, Conde-Ferreiros M, et al
    Cervical carcinosarcoma, report of some cases and a literature review.
    Int J Gynaecol Obstet. 2024;164:795-796.
    PubMed    
    
    
    
79. JIA L, Wang L, Zheng J, Lu J, et al
    Ureter metastasis from a primary cervical malignancy 3 years after initial treatment.
    Int J Gynaecol Obstet. 2024;164:793-794.
    PubMed    
    
    
    January 2024
80. LIANG C, Su G, Sun L, Zhao H, et al
    Comparison of the clinical outcomes of patients with stage IA-IIA2 cervical adenocarcinoma and squamous cell carcinoma after radical hysterectomy: A propensity score-matched real-world analysis.
    Int J Gynaecol Obstet. 2024 Jan 29. doi: 10.1002/ijgo.15388.
    PubMed     Abstract available
    
    
    
81. SABEENA S, Ravishankar N, Kalpana MM
    Implementation strategies of cervical cancer screening in South Asia: A systematic review.
    Int J Gynaecol Obstet. 2024 Jan 24. doi: 10.1002/ijgo.15366.
    PubMed     Abstract available
    
    
    
82. VAN DE SANDE AJM, Kengsakul M, Koeneman MM, Jozwiak M, et al
    The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2024;164:66-74.
    PubMed     Abstract available
    
    
    December 2023
83. TANG X, Zhang X, Ding Y, Zhang Y, et al
    A long-term retrospective analysis of management of cervical cancer during pregnancy.
    Int J Gynaecol Obstet. 2023 Dec 27. doi: 10.1002/ijgo.15314.
    PubMed     Abstract available
    
    
    
84. DESRAVINES N, Hsu CH, Mohnot S, Sahasrabuddhe V, et al
    Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
    Int J Gynaecol Obstet. 2023;163:862-867.
    PubMed     Abstract available
    
    
    November 2023
85. ZHANG Y, Wang C, Zhao Z, Cheng L, et al
    Survival outcomes of 2018 FIGO stage IIIC versus stages IIIA and IIIB in cervical cancer: A systematic review with meta-analysis.
    Int J Gynaecol Obstet. 2023 Nov 11. doi: 10.1002/ijgo.15218.
    PubMed     Abstract available
    
    
    
86. LUCKETT R, Ramogola-Masire D, Gompers A, Moraka N, et al
    Triage of HPV positivity in a high HIV prevalence setting: A prospective cohort study comparing visual triage methods and HPV genotype restriction in Botswana.
    Int J Gynaecol Obstet. 2023 Nov 10. doi: 10.1002/ijgo.15225.
    PubMed     Abstract available
    
    
    
87. HILL SK, Bempong-Ahun N, Okolo ID, Lalla AT, et al
    Improving access to safe, quality surgical care for gynecologic cancers through capacity-building interventions in low- and middle-income countries: A scoping review.
    Int J Gynaecol Obstet. 2023 Nov 5. doi: 10.1002/ijgo.15156.
    PubMed     Abstract available
    
    
    
88. RAMESAN CK, Calvin JD, Thomas A, Fletcher J, et al
    Diagnostic study of human papillomavirus DNA detection in cervical and vaginal samples using the filter paper card.
    Int J Gynaecol Obstet. 2023;163:660-666.
    PubMed     Abstract available
    
    
    October 2023
89. VARGAS-CARDONA HD, Rodriguez-Lopez M, Arrivillaga M, Vergara-Sanchez C, et al
    Artificial intelligence for cervical cancer screening: Scoping review, 2009-2022.
    Int J Gynaecol Obstet. 2023 Oct 9. doi: 10.1002/ijgo.15179.
    PubMed     Abstract available
    
    
    
90. REIJNTJES B, Eising M, Kleppe M, Geuken E, et al
    The clinical relevance of excisional margins after large loop excision of the transformation zone for the persistence of cervical dysplasia.
    Int J Gynaecol Obstet. 2023;163:140-147.
    PubMed     Abstract available
    
    
    
91. HAMAR B, Teutsch B, Hoffmann E, Hegyi P, et al
    Trichomonas vaginalis infection is associated with increased risk of cervical carcinogenesis: A systematic review and meta-analysis of 470 000 patients.
    Int J Gynaecol Obstet. 2023;163:31-43.
    PubMed     Abstract available
    
    
    September 2023
92. LIU Y, He J, Liu P, Chen C, et al
    Postoperative management of FIGO 2018 stage IIA1 cervical squamous cell carcinoma with only one intermediate-risk factor: Is radiotherapy needed?
    Int J Gynaecol Obstet. 2023;162:1098-1105.
    PubMed     Abstract available
    
    
    
93. ZHOU Y, Wang C, Li W, Lu W, et al
    Fluorescence colposcope with TMTP1-PEG4-ICG is comparable to the conventional colposcope in identifying cervical precancerous lesions: A randomized controlled trial.
    Int J Gynaecol Obstet. 2023;162:969-976.
    PubMed     Abstract available
    
    
    July 2023
94. AMARAL E, Cain JM, Hearing F, Lumsden MA, et al
    FIGO guidance for sustainable implementation of vaccination programs for women: Pregnancy and HPV.
    Int J Gynaecol Obstet. 2023;162 Suppl 1:3-23.
    PubMed    
    
    
    June 2023
95. BONI SP, Horo A, Didi-Kouko-Coulibaly J, Tanon A, et al
    Impact of HIV infection on access to cancer care and survival among women with invasive cervical cancer in Cote d'Ivoire: A prospective cohort study.
    Int J Gynaecol Obstet. 2023 Jun 22. doi: 10.1002/ijgo.14925.
    PubMed     Abstract available
    
    
    
96. KASUGA Y, Hasegawa K, Hamuro A, Fukuma Y, et al
    Pregnancy outcomes following radical trachelectomy for early-stage cervical cancer: A retrospective observational study in the Kanto area, Japan.
    Int J Gynaecol Obstet. 2023 Jun 21. doi: 10.1002/ijgo.14935.
    PubMed     Abstract available
    
    
    
97. TOGAMI S, Tokudome A, Fukuda M, Mizuno M, et al
    Validation of single-photon emission computed tomography with computed tomography and lymphoscintigraphy for sentinel lymph node identification in cervical cancer.
    Int J Gynaecol Obstet. 2023 Jun 18. doi: 10.1002/ijgo.14917.
    PubMed     Abstract available
    
    
    May 2023
98. DE LA CRUZ-RAMIREZ YM, Olaza-Maguina AF
    Barriers to HPV vaccine uptake in adolescents of the indigenous Andean community of Peru.
    Int J Gynaecol Obstet. 2023 May 5. doi: 10.1002/ijgo.14844.
    PubMed    
    
    
    April 2023
99. GIANNELLA L, Delli Carpini G, Di Giuseppe J, Gardella B, et al
    Should attention be paid to the cone depth in the fully visible transformation zone? Retrospective analysis of 517 patients with cervical intraepithelial neoplasia grade 3.
    Int J Gynaecol Obstet. 2023;161:137-143.
    PubMed     Abstract available
    
    
    
100. TEHRANIAN A, Ghahghaei-Nezamabadi A, Seifollahi A, Mansouri P, et al
     Concurrent anorectal and cervical cytology in women with positive and negative cervical smear test results: A cross-sectional study.
     Int J Gynaecol Obstet. 2023;161:100-105.
     PubMed     Abstract available
     
     
     February 2023
101. MCCLYMONT E, Money D
     The shift to one-dose HPV vaccination: Where does this leave women living with HIV?
     Int J Gynaecol Obstet. 2023 Feb 20. doi: 10.1002/ijgo.14713.
     PubMed    
     
     
     December 2022
102. MATSUO K, Violette CJ, Mandelbaum RS, Shoupe D, et al
     Utilizations and characteristics of ovarian conservation at hysterectomy for cervical carcinoma in-situ.
     Int J Gynaecol Obstet. 2022 Dec 1. doi: 10.1002/ijgo.14604.
     PubMed     Abstract available
     
     
     November 2022
103. BAO H, Zhao Y, Zhang X, Bi H, et al
     HPV-negative high-grade cervical precancerous lesions or invasive cancer in China: A post hoc analysis of a multicentric clinical study.
     Int J Gynaecol Obstet. 2022 Nov 29. doi: 10.1002/ijgo.14598.
     PubMed     Abstract available
     
     
     October 2022
104. JOHN JH, Halder A, Purwar S, Pushpalatha K, et al
     Study to determine efficacy of Urinary HPV 16 &18 detection in predicting premalignant and malignant lesions of Uterine Cervix.
     Int J Gynaecol Obstet. 2022 Oct 2. doi: 10.1002/ijgo.14486.
     PubMed     Abstract available
     
     
     September 2022
105. VORA KS, Saiyed S, Joshi R, Natesan S, et al
     Prevalence of High Risk HPV amongst marginalized urban women in India and its implications on vaccination: A cross sectional study.
     Int J Gynaecol Obstet. 2022 Sep 1. doi: 10.1002/ijgo.14428.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum